Indication
Urogenital Diseases
3 clinical trials
5 products
1 drug
Product
GedatolisibProduct
DarolutamideClinical trial
A Phase 1/2, Open-Label, Randomized, Dose Finding and Dose Expansion Study of Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)Status: Recruiting, Estimated PCD: 2025-11-01
Clinical trial
A Phase 2 Trial in Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without RelatlimabStatus: Recruiting, Estimated PCD: 2026-07-01
Product
NivolumabProduct
RelatlimabClinical trial
Phase II Trial of Neoadjuvant Immune-based Combinations in Patients Undergoing Nephrectomy for Locally Advanced ccRCCStatus: Recruiting, Estimated PCD: 2025-12-31
Drug
PD-1 antibodyProduct
Lenvatinib